Moderna, a US biotech company, announced on Thursday that it had submitted an emergency use authorisation request in the US for its COVID vaccination for…
An expert panel of India’s central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax as a booster dose…
Delhi on Thursday reported 326 fresh COVID-19 cases and three deaths, while the positivity rate stood at 0.77 percent, according to data shared by the city…
Biological E has sought emergency use authorisation from India’s drug regulator for its COVID-19 vaccine Corbevax for the 12 to 18 years age group, official…
India saw a single-day rise of 50,407 coronavirus infections, which took the tally of cases to 4,25,86,544, while the active cases have declined to 6,10,443,…
The weekend curfew in the national capital has been lifted, along with restrictions at markets and malls. Cinema halls and restaurants will be permitted to reopen…
A new coronavirus variant Deltacron has emerged in Cyprus which has a similar genetic background to the Delta variant, as well as some of the mutations from…
By Administrator_ India Capital Sands The Tamil Nadu state government has extended COVID-19 curbs till September 9 with additional relaxations. The existing relaxations were scheduled…
By Administrator_ India Capital Sands Bharat Biotech’s Covaxin is effective against the Delta and Delta plus variant, a study by the Indian Council of Medical…
By Administrator_ India Capital Sands Ahmedabad-based pharma major Cadila Healthcare (Zydus Cadila) is planning to start clinical trials on children aged 5 years and above…